Physician profile
Hannah Canuto
NPI 1568020725
$3,187.64
in general payments reported to CMS, 2019-2025
18 companies · $1,409 in 2025
The $1,409 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.92 · 2020: $29.57 · 2021: $131 · 2022: $110 · 2023: $407 · 2024: $1,085 · 2025: $1,409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,902.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $822.97 | 2024-2025 | Infuse, Miebo, Xiidra |
| Coopervision INC. | $354.85 | 2021-2025 | Misight Contact Lens, Paragon Crt |
| Alcon Vision LLC | $264.56 | 2022-2025 | Precision 1, Tryptyr, Precision7 |
| Dompe US, INC. | $240.57 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $239.57 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $212.51 | 2022-2025 | Acuvue |
| Rxsight INC | $165.13 | 2022-2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
| Biotissue Holdings INC. | $142.09 | 2024 | |
| Sight Sciences, INC. | $130.71 | 2023 | Tearcare System |
| Harrow Eye, LLC | $130.55 | 2024-2025 | Vevye |
| Topcon Healthcare, INC. | $106.66 | 2024 | |
| Mallinckrodt Hospital Products INC. | $105.87 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $104.41 | 2019-2021 | |
| Lkc Technologies, INC. | $83.34 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $42.07 | 2023 | Catalys System, Tecnis Simplicity, Tecnis Iol |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $17.13 | 2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $13.31 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Canuto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.